Harrow Health Inc's stock soared 6.93% in pre-market trading on Friday, following news of significant insider buying by the company's leadership.
The pre-market surge came after a regulatory filing revealed that Harrow President and Chief Financial Officer Andrew R. Boll purchased 3,500 common shares in open-market transactions at $29.90 per share, totaling approximately $104,650. Following this purchase, Boll's directly held stake in the company increased to 814,679 shares.
Such insider buying activity is often viewed by investors as a strong vote of confidence from company executives, signaling their belief in the company's future prospects and potentially indicating that the stock is undervalued at current levels.